Literature DB >> 7186826

Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.

N J Cusack, S M Hourani.   

Abstract

Some 2-alkylthio derivatives of adenosine 5'-monophosphate (AMP), adenosine 5'-monophosphorothioate (AMPS) and adenosine 5'-triphosphate (ATP) were examined as inhibitors of human platelet aggregation. 2-Methylthio-AMP, 2-ethylthio-AMP, 2-(pentan-l-yl)thio-AMP, 2-ethylthio-AMPS, 2-methylthio-ATP and 2-ethylthio-ATP (100 microM) each inhibited aggregation induced by adenosine 5'-diphosphate (ADP) but not by 11 alpha, 9 alpha-epoxymethano prostaglandin H2, a stable endoperoxide analogue. Log dose-response curves to ADP in the absence and presence of each inhibitor were not parallel and the inhibition could not be overcome by high concentrations of ADP. The ATP analogues achieved greater inhibition of aggregation induced by ADP (5 microM) than did the AMP analogues. The order of potency of the AMP analogues was 2-ethylthio-AMPS greater than 2-ethylthio-AMP greater than 2-(pentan-l-yl)thio-AMP greater than 2-methylthio-AMP, and 2-methylthio-ATP was more potent than 2-ethylthio-ATP. These 2-alkylthio substituted analogues of AMP and ATP are specific but noncompetitive inhibitors of ADP-induced human platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7186826      PMCID: PMC2071616          DOI: 10.1111/j.1476-5381.1982.tb08800.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Effects of photolysable 2-azido analogues of adenosine, AMP and ADP on human platelets.

Authors:  N J Cusack; G V Born
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-07-20

2.  Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.

Authors:  M J Harrison; R Brossmer
Journal:  Thromb Haemost       Date:  1976-11-30       Impact factor: 5.249

3.  Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates.

Authors:  M J Harrison; R Brossmer
Journal:  FEBS Lett       Date:  1975-06-01       Impact factor: 4.124

4.  Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.

Authors:  R J Haslam; G M Rosson
Journal:  Mol Pharmacol       Date:  1975-09       Impact factor: 4.436

5.  The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.

Authors:  D E Macfarlane; D C Mills
Journal:  Blood       Date:  1975-09       Impact factor: 22.113

6.  Platelet aggregation inhibitors. IX. Chemical transformation of adenosine into 2-thioadenosine derivatives.

Authors:  K Kikugawa; H Suehiro; R Yanase; A Aoki
Journal:  Chem Pharm Bull (Tokyo)       Date:  1977-08       Impact factor: 1.645

7.  Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.

Authors:  D E MacIntyre; E W Salzman; J L Gordon
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

8.  Platelet aggregation inhibitors. 7. S-substituted 2-thioadenosine 5'-monophosphates.

Authors:  K Kikugawa; H Suehiro; M Ichino
Journal:  J Med Chem       Date:  1973-12       Impact factor: 7.446

9.  Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma.

Authors:  F Michal; G V Born
Journal:  Nat New Biol       Date:  1971-06-16

10.  Effects of D- and L- enantiomers of adenosine, AMP and ADP and their 2-chloro- and 2-azido- analogues on human platelets.

Authors:  N J Cusack; M E Hickman; G V Born
Journal:  Proc R Soc Lond B Biol Sci       Date:  1979-11-30
View more
  10 in total

1.  Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.

Authors:  H S Park; S M Hourani
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.

Authors:  Susanne Horner; Kirsten Menke; Caren Hildebrandt; Matthias U Kassack; Peter Nickel; Heiko Ullmann; Martyn P Mahaut-Smith; Günter Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-09-13       Impact factor: 3.000

3.  FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.

Authors:  R G Humphries; W Tomlinson; A H Ingall; P A Cage; P Leff
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

4.  Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.

Authors:  D A Hall; S M Hourani
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

5.  Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

6.  Racial differences in resistance to P2Y12 receptor antagonists in type 2 diabetic subjects.

Authors:  John H Cleator; Matthew T Duvernay; Michael Holinstat; Nancy E Colowick; Willie J Hudson; Yanna Song; Frank E Harrell; Heidi E Hamm
Journal:  J Pharmacol Exp Ther       Date:  2014-07-22       Impact factor: 4.030

7.  Characterization of the effects of 2-methylthio-ATP and 2-chloro-ATP on brain capillary endothelial cells: similarities to ADP and differences from ATP.

Authors:  P Vigne; E Feolde; J P Breittmayer; C Frelin
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

8.  Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo.

Authors:  R G Humphries; W Tomlinson; J A Clegg; A H Ingall; N D Kindon; P Leff
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

Review 9.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

10.  Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.